Delivery Order SPE2DE24DA010-SPE2D626F610X
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570109351) valued at $6,874.00 from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by December 1, 2025. The award carries no set-aside designation and represents a discrete delivery order issued under Abbott's established...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a delivery order award valued at $8,901.70 from the Defense Logistics Agency's Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 10, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and is for performance in Santa Clara, California. The delivery order represents a task order against Abbott Vascular's larger Indefinite Delivery Contract with the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F610XDelivery Order
Abbott Laboratories Inc. through its Abbott Vascular Inc. division received a $11,750 fixed-price delivery order (4570134220) from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025, with completion targeted for December 1, 2025. The award carries no set-aside designation and represents work to be performed in Santa Clara, California. This delivery order falls under Abbott Vascular's established cardiovascular medical technology portfolio, which includes specialized implantable devices, surgical instrumentation, and related procedural support materials. The compressed performance timeline and modest contract value are consistent with the delivery order mechanism, which typically addresses discrete, time-sensitive procurement needs within larger indefinite delivery contract vehicles. Abbott Vascular has established itself as a critical federal supplier of cardiovascular technologies to the Defense Logistics Agency Medical Supply Chain, supported by a major $117.1 million indefinite delivery contract that has generated numerous task orders throughout 2024 and 2025. The company's federal contracting experience encompasses comprehensive procurement of cardiovascular devices ranging from stents and pacemakers to transcatheter valve repair systems and left ventricular assist devices, with demonstrated competitive success across multiple Veterans Integrated Service Networks and Defense Health Agency programs. This award reflects the continuation of Abbott's strategic role in supporting federal healthcare procurement infrastructure for military and veteran patient populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 11/24/25 |